Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Virtus Biotech Clinical Trials ETF BBC

Full chart Compare
Set alert

Price alert · BBC

All alert types
42.81 USD +1.03 (+2.47%)

At closeNov 3, 2026, 4:00 PM EST

42.81 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

42.70 Day range 43.21
28.73 52-week range 56.18
YTD
+11.02%
1 year
+38.32%

Virtus Biotech Clinical Trials ETF

Issuer
Virtus
Asset class
Sector Equity
Expense ratio
0.65%
Assets under management
$34.42M
NAV
43.02
Holdings
198
Inception
2014-12-16
Top 10 weight
16.14%

Top holdings

  1. KOD Kodiak Sciences Inc 2.26%
  2. TRAX First Tracks Biotherapeutics Inc 1.98%
  3. XNCR Xencor Inc 1.88%
  4. ABCL AbCellera Biologics Inc 1.82%
  5. REPL Replimune Group Inc 1.54%
  6. AMLX Amylyx Pharmaceuticals Inc 1.54%
  7. SGP SpyGlass Pharma Inc 1.36%
  8. PRME Prime Medicine Inc 1.32%
  9. NRIX Nurix Therapeutics Inc 1.23%
  10. MBX MBX Biosciences Inc 1.22%
  11. VRDN Viridian Therapeutics Inc 1.17%
  12. KYMR Kymera Therapeutics Inc 1.14%
  13. DFTX Definium Therapeutics Inc 1.14%
  14. MANE VeraDermics Inc 1.13%
  15. ZBIO Zenas Biopharma Inc 1.11%
  16. LBRX LB Pharmaceuticals Inc 1.08%
  17. ORKA Oruka Therapeutics Inc 1.08%
  18. VOR Vor BioPharma Inc 1.06%
  19. BHVN Biohaven Ltd 1.06%
  20. FDMT 4D Molecular Therapeutics Inc 1.05%
  21. PVLA Palvella Therapeutics Inc 1.04%
  22. VIR Vir Biotechnology Inc 1.02%
  23. MAZE Maze Therapeutics Inc 1.02%
  24. PCVX Vaxcyte Inc 1.01%
  25. JANX Janux Therapeutics Inc 1.00%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 90.01%
  • Canada 2.44%
  • United Kingdom 2.25%
  • Netherlands 2.04%
  • Ireland 1.59%
  • Switzerland 1.07%
  • China 0.60%

Updated 2026-11-02